Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
ATLCAR.CD138 T Cells for Multiple Myeloma
Recruiting1 awardPhase 1
Chapel Hill, North Carolina
This trial is studying whether adding the anti-CD138 antibody to T cells can improve the T cells' ability to kill cancer cells and whether it can help to control the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service